πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Theravance Biopharma Ireland Patents

Full USPTO pharma patent portfolio for Theravance Biopharma Ireland β€” grant dates, expiration, and drug cross-links.

Patents
635
Expiring ≀24m
58

Quick answer

Theravance Biopharma Ireland has 635 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 58 expire within 24 months β€” use filters for patent-cliff planning.

Page 8 of 14

  1. US 8324236

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8318765

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8314217

    Cross-linked glycopeptide-cephalosporin antibiotics

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8314128

    Aminotetralin compounds as mu opioid receptor antagonists

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8304433

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8304432

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8288550

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8273786

    3-phenoxymethylpyrrolidine compounds

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8273894

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8268863

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8263618

    8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8247433

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8247555

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8247564

    Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8242138

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8242137

    Crystalline forms of a biphenyl compound

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8242135

    Biphenyl derivatives

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8242164

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8236839

    Dual-acting antihypertensive agents

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8236846

    Dual-acting antihypertensive agents

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8227497

    Dual-acting antihypertensive agents

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8211894

    Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8211915

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8212052

    Dual-acting benzoimidazole antihypertensive agents

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8202891

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8198304

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8188294

    Process for preparing biphenyl imidazole compounds

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8173815

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8163920

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8163794

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8158659

    Dual-acting imidazole antihypertensive agents

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8158580

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8153686

    Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8153675

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8143277

    Method of using compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8143279

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8143298

    Dual-acting antihypertensive agents

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8138345

    Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonist activity

    Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8133905

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8134006

    Dialkylphenyl compounds having Ξ²2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8124627

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8119796

    Biphenyl compounds useful as muscarinic receptor antagonists

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8119634

    Dual-acting pyrazole antihypertensive agents

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8106232

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8106082

    Dual-acting antihypertensive agents

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8101575

    Glycopeptide phosphonate derivatives

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8101766

    Crystalline form of a biphenyl compound

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8101791

    Aminotetralin compounds as mu opioid receptor antagonists

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Theravance Biopharma Ireland have?

635 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Theravance Biopharma Ireland patents expire?

58 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.